Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Wesbey

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Pharmaceutical Research|November 27, 2013
Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imagingW R Couet, U G Eriksson, T N Tozer, et al.
Radiology|June 1, 1994
Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trialR F Mattrey, M A Trambert, J J Brown, et al.
Magnetic Resonance Imaging|January 1, 1985
Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agentR L Ehman, G E Wesbey, K L Moon, et al.
Radiology|October 1, 1984
Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardiumG E Wesbey, C B Higgins, M T McNamara, et al.
Radiology|June 1, 1983
Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animalsR C Brasch, D A London, G E Wesbey, et al.
AJR. American Journal of Roentgenology|November 1, 1983
Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary reportR C Brasch, D E Nitecki, M Brant-Zawadzki, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Pharmaceutical Research|November 27, 2013
Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imagingW R Couet, U G Eriksson, T N Tozer, et al.
Radiology|June 1, 1994
Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trialR F Mattrey, M A Trambert, J J Brown, et al.
Magnetic Resonance Imaging|January 1, 1985
Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agentR L Ehman, G E Wesbey, K L Moon, et al.
Radiology|October 1, 1984
Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardiumG E Wesbey, C B Higgins, M T McNamara, et al.
Radiology|June 1, 1983
Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animalsR C Brasch, D A London, G E Wesbey, et al.
AJR. American Journal of Roentgenology|November 1, 1983
Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary reportR C Brasch, D E Nitecki, M Brant-Zawadzki, et al.
Pageof 3